메뉴 건너뛰기




Volumn 46, Issue 2, 2007, Pages 608-

Reply [8]

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; BILIRUBIN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; PLACEBO; VIRUS ANTIGEN; VIRUS DNA;

EID: 34548321203     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.21882     Document Type: Letter
Times cited : (1)

References (6)
  • 1
    • 0028796357 scopus 로고
    • Bone marrow is a major site of long-term antibody production after acute viral infection
    • Slifka MR, Matloubian M, Ahmed R. Bone marrow is a major site of long-term antibody production after acute viral infection. J Virol 1995;69:1895-1902.
    • (1995) J Virol , vol.69 , pp. 1895-1902
    • Slifka, M.R.1    Matloubian, M.2    Ahmed, R.3
  • 2
    • 0030036180 scopus 로고    scopus 로고
    • Bocker WO, Herzog-Hauff S, Herr W, Hermann K, Gerken G, Meyer Zum Buschenfelde KH, et al. Regulation of the neutralizing anti-hepatitis B surface (HBs) antibody response in vitro in HBs vaccine recipients and patients with acute or chronic hepatitis B virus (HBV) infection. Clin Exp Immunol 1996;105:52-58.
    • Bocker WO, Herzog-Hauff S, Herr W, Hermann K, Gerken G, Meyer Zum Buschenfelde KH, et al. Regulation of the neutralizing anti-hepatitis B surface (HBs) antibody response in vitro in HBs vaccine recipients and patients with acute or chronic hepatitis B virus (HBV) infection. Clin Exp Immunol 1996;105:52-58.
  • 5
    • 3042774427 scopus 로고    scopus 로고
    • Early lamuvidine therapy may prevent liver failure in patients with fulminant hepatitis B [Abstract]
    • Tillman HL, Wedemeyer H, Hadem J, Rudolph T, Dick A, Schedel I, et al. Early lamuvidine therapy may prevent liver failure in patients with fulminant hepatitis B [Abstract]. HEPATOLOGY 2002;36:375A.
    • (2002) HEPATOLOGY , vol.36
    • Tillman, H.L.1    Wedemeyer, H.2    Hadem, J.3    Rudolph, T.4    Dick, A.5    Schedel, I.6
  • 6
    • 33846447769 scopus 로고    scopus 로고
    • A randomized controlled trial of lamivudine to treat acute hepatitis B
    • Kumar M, Satapathy S, Mongia R, Das K, Hissar S, Pande C, et al. A randomized controlled trial of lamivudine to treat acute hepatitis B. HEPATOLOGY 2007;45:97-101.
    • (2007) HEPATOLOGY , vol.45 , pp. 97-101
    • Kumar, M.1    Satapathy, S.2    Mongia, R.3    Das, K.4    Hissar, S.5    Pande, C.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.